115 related articles for article (PubMed ID: 31255330)
1. PRKDC is a prognostic marker for poor survival in gastric cancer patients and regulates DNA damage response.
Zhang Y; Wen GM; Wu CA; Jing ZL; Li DZ; Liu GL; Wei XX; Tang MS; Li YH; Zhong Y; Deng YJ; Yang WK
Pathol Res Pract; 2019 Aug; 215(8):152509. PubMed ID: 31255330
[TBL] [Abstract][Full Text] [Related]
2. High expression of PRKDC promotes breast cancer cell growth via p38 MAPK signaling and is associated with poor survival.
Zhang Y; Yang WK; Wen GM; Tang H; Wu CA; Wu YX; Jing ZL; Tang MS; Liu GL; Li DZ; Li YH; Deng YJ
Mol Genet Genomic Med; 2019 Nov; 7(11):e908. PubMed ID: 31513357
[TBL] [Abstract][Full Text] [Related]
3. PRKDC regulates chemosensitivity and is a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients.
Sun G; Yang L; Dong C; Ma B; Shan M; Ma B
Oncol Rep; 2017 Jun; 37(6):3536-3542. PubMed ID: 28498431
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer.
Zhou Y; Liu F; Xu Q; Yang B; Li X; Jiang S; Hu L; Zhang X; Zhu L; Li Q; Zhu X; Shao H; Dai M; Shen Y; Ni B; Wang S; Zhang Z; Teng Y
Oncogene; 2020 Aug; 39(34):5633-5648. PubMed ID: 32661323
[TBL] [Abstract][Full Text] [Related]
6. DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells.
Dolman ME; van der Ploeg I; Koster J; Bate-Eya LT; Versteeg R; Caron HN; Molenaar JJ
PLoS One; 2015; 10(12):e0145744. PubMed ID: 26716839
[TBL] [Abstract][Full Text] [Related]
7. Identification of PRKDC (Protein Kinase, DNA-Activated, Catalytic Polypeptide) as an essential gene for colorectal cancer (CRCs) cells.
Sun S; Cheng S; Zhu Y; Zhang P; Liu N; Xu T; Sun C; Lv Y
Gene; 2016 Jun; 584(1):90-96. PubMed ID: 26992638
[TBL] [Abstract][Full Text] [Related]
8. Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening.
Zhou Z; Patel M; Ng N; Hsieh MH; Orth AP; Walker JR; Batalov S; Harris JL; Liu J
BMC Cancer; 2014 Dec; 14():944. PubMed ID: 25495526
[TBL] [Abstract][Full Text] [Related]
9. Synergy between Prkdc and Trp53 regulates stem cell proliferation and GI-ARS after irradiation.
Gurley KE; Ashley AK; Moser RD; Kemp CJ
Cell Death Differ; 2017 Nov; 24(11):1853-1860. PubMed ID: 28686579
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9-mediated knockout of the Prkdc in mouse embryonic stem cells leads to the modulation of the expression of pluripotency genes.
Soleimani F; Babaei E; H Feizi MA; Fathi F
J Cell Physiol; 2020 Apr; 235(4):3994-4000. PubMed ID: 31603250
[TBL] [Abstract][Full Text] [Related]
11. Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer.
Yang X; Yang F; Lan L; Wen N; Li H; Sun X
Medicine (Baltimore); 2022 Jul; 101(27):e29628. PubMed ID: 35801800
[TBL] [Abstract][Full Text] [Related]
12. Impairment of the non-homologous end joining and homologous recombination pathways of DNA double strand break repair: Impact on spontaneous and radiation-induced mammary and intestinal tumour risk in Apc min/+ mice.
Haines JW; Coster M; Bouffler SD
DNA Repair (Amst); 2015 Nov; 35():19-26. PubMed ID: 26435054
[TBL] [Abstract][Full Text] [Related]
13. p53-Independent apoptosis disrupts early organogenesis in embryos lacking both ataxia-telangiectasia mutated and Prkdc.
Gladdy RA; Nutter LM; Kunath T; Danska JS; Guidos CJ
Mol Cancer Res; 2006 May; 4(5):311-8. PubMed ID: 16687486
[TBL] [Abstract][Full Text] [Related]
14. Emerging functions of PRKDC in the initiation and progression of cancer.
Yin Y; He Q; Li Y; Long J; Lei X; Li Z; Zhu W
Tumori; 2021 Dec; 107(6):483-488. PubMed ID: 32867618
[TBL] [Abstract][Full Text] [Related]
15. Variations in Prkdc and susceptibility to benzene-induced toxicity in mice.
Faiola B; Bauer AK; Fuller ES; Wong VA; Pluta LJ; Abernethy DJ; Mangum JB; Everitt JI; Recio L
Toxicol Sci; 2003 Oct; 75(2):321-32. PubMed ID: 12857942
[TBL] [Abstract][Full Text] [Related]
16. Primary Founder Mutations in the
Pálinkás HL; Pongor L; Balajti M; Nagy Á; Nagy K; Békési A; Bianchini G; Vértessy BG; Győrffy B
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054819
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors.
Riabinska A; Daheim M; Herter-Sprie GS; Winkler J; Fritz C; Hallek M; Thomas RK; Kreuzer KA; Frenzel LP; Monfared P; Martins-Boucas J; Chen S; Reinhardt HC
Sci Transl Med; 2013 Jun; 5(189):189ra78. PubMed ID: 23761041
[TBL] [Abstract][Full Text] [Related]
18. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
19. Murine Prkdc polymorphisms impact DNA-PKcs function.
Fabre KM; Ramaiah L; Dregalla RC; Desaintes C; Weil MM; Bailey SM; Ullrich RL
Radiat Res; 2011 Apr; 175(4):493-500. PubMed ID: 21265624
[TBL] [Abstract][Full Text] [Related]
20. Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining.
Houghtaling S; Newell A; Akkari Y; Taniguchi T; Olson S; Grompe M
Hum Mol Genet; 2005 Oct; 14(20):3027-33. PubMed ID: 16135554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
